Harvard Bioscience (HBIO) Net Margin (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Net Margin of 16.5% for Q1 2026, up 21448.0% year-over-year from N/an in Q1 2025, and down 38.95% quarter-over-quarter from 11.87% in Q4 2025.
Harvard Bioscience (HBIO) Net Margin (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Net Margin for 16 consecutive years, with 16.5% the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Margin rose 21448.0% year-over-year to 16.5%; the TTM figure through Mar 2026 stood at 11.41% (up 5167.0% YoY), while the FY2025 annual figure was 65.51%, down 5266.0% from the prior year.
- Net Margin fell to 16.5% in Q1 2026 per HBIO's latest filing, from 11.87% in the prior quarter.
- Across five years, Net Margin topped out at 8.34% in Q2 2022 and bottomed at 230.98% in Q1 2025.
- Historically, Net Margin has averaged 21.81% across 5 years, with a median of 11.17% in 2025.
- Annual changes were most pronounced in 2025 — Net Margin tumbled 21183 bps — and 2026, when it soared 21448 bps.
- Harvard Bioscience's Net Margin stood at 5.86% in 2022, then soared by 72 bps to 1.66% in 2023, then jumped by 189 bps to 1.47% in 2024, then sank by 910 bps to 11.87% in 2025, then plunged by 39 bps to 16.5% in 2026.
- Business Quant data shows HBIO's Net Margin at 16.5% in Q1 2026, 11.87% in Q4 2025, and 5.98% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 28.46% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 7.59% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 26.20% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 1.81% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 16.96% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 4.21% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -7.20% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 4.26% |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -12.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.80% |
| Mar 31, 2026 | -16.50% |
| Dec 31, 2025 | -11.87% |
| Sep 30, 2025 | -5.98% |
| Jun 30, 2025 | -11.17% |
| Mar 31, 2025 | -230.98% |
| Dec 31, 2024 | 1.47% |
| Sep 30, 2024 | -21.81% |
| Jun 30, 2024 | -12.67% |
| Mar 31, 2024 | -19.15% |
| Dec 31, 2023 | -1.66% |
| Sep 30, 2023 | -4.89% |
| Jun 30, 2023 | -3.41% |
| Mar 31, 2023 | 2.03% |
| Dec 31, 2022 | -5.86% |
| Sep 30, 2022 | -12.65% |
| Jun 30, 2022 | 8.34% |
| Mar 31, 2022 | -24.04% |
| Dec 31, 2021 | 3.44% |
| Sep 30, 2021 | -0.57% |